SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

Yu Evan Y.; Li Hongli; Higano Celestia S.; Agarwal Neeraj; Pal Sumanta K.; Alva Ajjai; Heath Elisabeth I.; Lam Elaine T.; Gupta Shilpa; Lilly Michael B.; Inoue Yoshio; Chi Kim N.; Vogelzang Nicholas J.; Quinn David I.; Cheng Heather H.; Plymate Stephen R.; Hussain Maha; Tangen Catherine M.; Thompson Ian M.

首页> 外文期刊>Journal of Clinical Oncology >SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

【24h】

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

机译：SWOG S0925：新型II期转移性激素敏感性前列腺癌患者中雄激素剥夺联合西妥昔单抗与单独雄激素剥夺的随机II期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2015年第14期|共10页
作者
Yu Evan Y.; Li Hongli; Higano Celestia S.; Agarwal Neeraj; Pal Sumanta K.; Alva Ajjai; Heath Elisabeth I.; Lam Elaine T.; Gupta Shilpa; Lilly Michael B.; Inoue Yoshio; Chi Kim N.; Vogelzang Nicholas J.; Quinn David I.; Cheng Heather H.; Plymate Stephen R.; Hussain Maha; Tangen Catherine M.; Thompson Ian M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer [J] . Yu Evan Y., Li Hongli, Higano Celestia S., Journal of Clinical Oncology . 2015,第14期

机译：SWOG S0925：新型II期转移性激素敏感性前列腺癌患者中雄激素剥夺联合西妥昔单抗与单独雄激素剥夺的随机II期研究
2. Re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial [J] . Shinde Ashwin, Li Richard, Amini Arya, European urology . 2019,第3期

机译：Re：Liselotte Ms Boeve，Maarten CCM Hulshof，Andre N. Vis等人。与雄激素剥夺治疗相比，对雄激素剥夺治疗的生存对雄激素剥夺治疗与前瞻性随机临床试验中原发性骨转移前列腺癌前列腺患者的同时剥夺治疗的影响：来自血腥审判的数据。 EUR UROL 2019; 75：410-8转移性前列腺癌中的明确治疗的未来步骤：来自血轮试验的教训
3. ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J] . Armstrong Andrew J., Szmulewitz Russell Z., Petrylak Daniel P., Journal of Clinical Oncology . 2019,第32期

机译：拱门：用转移激素敏感的前列腺癌的苯甲丁胺或安慰剂与苯甲酰胺或安慰剂的随机，第三阶段研究雄激素剥夺治疗
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer [O] . Evan Y. Yu, Hongli Li, Celestia S. Higano, -1

机译：SWOG S0925：新型II期转移性激素敏感性前列腺癌患者中雄激素剥夺联合西妥昔单抗与单独雄激素剥夺的随机II期研究
7. SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer [O] . Evan Y. Yu, Hongli Li, Celestia S. Higano, 2015

机译：Swog S0925：随机剥夺雄激素剥夺的随机期II研究与Cixutumumab与雄激素剥夺单独患有新转移激素敏感前列腺癌的患者

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅